New Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has fixed retail prices for 28 essential drug formulations including a wide range of combination drugs commonly prescribed for diabetes, hypertension, allergies, infections, and gastrointestinal conditions.

The prices, determined under the Drugs (Prices Control) Order, 2013 (DPCO), are exclusive of Goods and Services Tax (GST) and apply to specific manufacturers and marketing companies that applied under Form-I for price fixation.

The formulations include combinations such as Amlodipine with Valsartan, Dapagliflozin with Sitagliptin and Metformin, Empagliflozin with Linagliptin or Sitagliptin and Metformin, Telmis

See Full Page